Background: Managing a Complex Technology Transfer for Effervescent Products
When Johnson & Johnson (J&J) decided to purchase all of Pfizer’s consumer products, including the Efferdent brand, the multinational pharma manufacturing giant experienced for the first time the complicated intricacies of technology transfer for effervescent products.
Challenges in the Pharma Technology Transfer Process
The Efferdent brand was being manufactured at a Pfizer facility in Puerto Rico, so J&J required a transfer of the assets to a supplier in its network. However, very few suppliers had a dedicated Technology Transfer Team capable of making the numerous transitions required, while simultaneously maintaining uninterrupted supply deliveries and keeping the process as seamless and precise as possible.
Pharma Tech Industries’ Solution for Effervescent Manufacturing
Pharma Tech Industries determined an innovative way to expand its pharmaceutical CDMO services for potential customers like J&J. A specialized team was formed to construct custom low- humidity suites for the manufacturing and packaging processes of the operation by leveraging their knowledge of powder transfer using a pneumatic system. This enabled Pharma Tech Industries to engineer an entirely new and improved pharmaceutical manufacturing operation with the ability to transfer the compression and packaging lines from Puerto Rico to its facility in Royston, Georgia.
Producing 3 BILLION effervescent tablets a year? No problem!
Through a combination of expertise in pharma manufacturing and innovative use of pharmaceutical packaging technologies, PTI provided a seamless technology transfer process, demonstrating the CDMO’s ability to navigate challenging logistical situations while delivering complex products.
Delivering Results: A Billion-Tablet Milestone
Manufacturing such a high volume of effervescent products in 2008 was a milestone for Pharma Tech Industries’ Royston facility, marking the company’s largest tech transfer to date. But that was only the beginning. Pharma Tech Industries can now manufacture approximately three billion effervescent tablets a year. And Pharma Tech Industries’ Technology Transfer Team has consistently demonstrated that it can learn, optimize and execute new technologies and processes - even with limited previous experience with the dosage form.